We are pleased to announce that Skinive has received CE Mark clearance in the European Union.
The CE marking confirms that Skinive solutions meet the requirements of the European Medical Devices Directive (MDD). This clearance opens up the market significantly for our solutions. The CE mark covers 27 countries in the European Union. More importantly it validates our AI-powered solution as credible option and gives physicians and patients within the EU access to a reliable tool so they can identify skin conditions in an affordable and accessible manner.
As we stand today, We are proud to say we have achieved this.
Skinive offers disruptive, comprehensive deep-tech diagnostic and monitoring solutions for home and professional use.
We possess an innovative product, based on AI and our own database.
The tool for early-stage diagnostics and monitoring of skin pathologies available for everyone.
“Receiving CE mark reinforces our mission to urgently deliver our technology to patients around the world and we are excited to get started” Kirill Sokolov, CEO of Skinive Holding.
The device will aid dermatologists, doctors and nurses in obtaining a quick second opinion and improve detection of dermatologic conditions.
It will also bring great value to patients as receiving care in the comfort of their own homes.
Recommended articles preview:
1st June 2010
[AI Generated] All About Common Skin Disorders.
OpenAI NN input: Skin disorders vary greatly in symptoms and severity. They can be temporary or permanent, and may be painless or painful. Some have situational causes, while others may be genetic. Some skin conditions are minor, and others can be life-threatening. While most skin disorders are minor, others can indicate a more serious issue. […]
10th December 2018
How Machine Learning Technology Detects Skin Diseases
While you most likely don’t realize it, machine learning is often used in your daily life. For example, when social media suggests tagging your friends in pictures because it recognizes them, or the spam filter on your email account removing unwanted emails. In healthcare, machine learning also takes its part in recognizing skin cancer. Machine […]
2nd June 2021
Invitation to the International DEBRA Congress 2021 on Epidermolysis Bullosa
We are pleased to announce that Skinive has become an information partner of DEBRA Russia, which is part of the international organization DEBRA International and provides comprehensive assistance to butterfly children diagnosed with epidermolysis bullosa (EB) in Russia and the CIS. We invite you to the DEBRA Annual International Congress 2021. The Congress will take […]